Back to Duquesne Family Office LLC

NAMS
7 quarters

Position history for Duquesne Family Office LLC's holdings in NEWAMSTERDAM PHARMA COMPANY

Duquesne Family Office LLC holds 3.1M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $98.3M as of 2026-Q1. NAMS represents 2.9% of Duquesne Family Office LLC's portfolio.

Current Value

$98.3M

Current Shares

3.1M

Total Value Change

+$93.5M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
3.1M
0.0%
$98.3M2.9%$30.41
0
2025-Q4
Increased
3.1M
+59.6%
$107.7M2.4%$34.74
74
2025-Q3
Increased
1.9M
+131.2%
$54.7M1.3%$27.52
75
2025-Q2
Increased
832,175
+4.0%
$15.1M0.4%$18.57
35
2025-Q1
Increased
800,360
+178.3%
$16.4M0.5%$21.76
65
2024-Q4
Unchanged
287,535
0.0%
$7.4M0.2%$25.60
0
2024-Q3
New
287,535
-
$4.8M0.2%$16.23
45

Other major holders of NAMS: Capital World Investors, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used